News Related to Sequel Med Tech

Related coverage linked through entity extraction aliases.

Arecor seeks broader AT278 partnership as phase II trial start is targeted for 2026

Apr 13, 2026

Arecor said it is in talks on a broader AT278 partnership as it targets a phase II trial start in the second half of 2026. The company also cited FDA feedback, Ligand financing and year-end cash of £6.1 million.

Sequel and Senseonics Launch twiist Insulin Pump with Eversense 365 CGM Nationwide

Mar 09, 2026

Sequel Med Tech and Senseonics announced full U.S. availability of the twiist Automated Insulin Delivery System integrated with the Eversense 365 CGM, the world's only one-year continuous glucose monitor, for people with type 1 diabetes.